Marta Sobas

1.3k total citations
32 papers, 440 citations indexed

About

Marta Sobas is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Marta Sobas has authored 32 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 23 papers in Hematology and 8 papers in Rheumatology. Recurrent topics in Marta Sobas's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (8 papers). Marta Sobas is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (8 papers). Marta Sobas collaborates with scholars based in Poland, Spain and United States. Marta Sobas's co-authors include Radek C. Skoda, Jürg Schwaller, Stephan Dirnhofer, Hui Hao-Shen, Renate Looser, Ralph Tiedt, Tomasz Wróbel, Stephen T. Oh, Manuel Pérez‐Encinas and Maria Podolak‐Dawidziak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marta Sobas

26 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Sobas Poland 7 388 271 255 146 54 32 440
Gautam Borthakur United States 12 215 0.6× 415 1.5× 211 0.8× 92 0.6× 82 1.5× 83 494
Damien Luque Paz France 10 220 0.6× 188 0.7× 132 0.5× 87 0.6× 22 0.4× 35 329
Giacomo Coltro Italy 12 501 1.3× 440 1.6× 275 1.1× 181 1.2× 17 0.3× 32 563
Susanna Akiki Qatar 9 141 0.4× 219 0.8× 167 0.7× 58 0.4× 37 0.7× 32 347
Jacob Grinfeld United Kingdom 11 277 0.7× 228 0.8× 177 0.7× 112 0.8× 28 0.5× 19 365
Guntram Buesche Germany 12 390 1.0× 396 1.5× 170 0.7× 149 1.0× 28 0.5× 20 513
Yumi Hironaka Japan 10 327 0.8× 265 1.0× 240 0.9× 75 0.5× 24 0.4× 13 424
Sabrina Cordua Denmark 8 235 0.6× 187 0.7× 102 0.4× 88 0.6× 28 0.5× 15 304
Shireen Sirhan Canada 14 557 1.4× 384 1.4× 331 1.3× 250 1.7× 37 0.7× 35 594
Borhane Slama France 7 132 0.3× 147 0.5× 91 0.4× 51 0.3× 25 0.5× 29 240

Countries citing papers authored by Marta Sobas

Since Specialization
Citations

This map shows the geographic impact of Marta Sobas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Sobas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Sobas more than expected).

Fields of papers citing papers by Marta Sobas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Sobas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Sobas. The network helps show where Marta Sobas may publish in the future.

Co-authorship network of co-authors of Marta Sobas

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Sobas. A scholar is included among the top collaborators of Marta Sobas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Sobas. Marta Sobas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gąsior‐Głogowska, Marlena, Paweł Karpiński, Łukasz Łaczmański, et al.. (2025). Flow cytometry-based targeted diagnostics for rapid assessment of daunorubicin resistance in acute myeloid leukemia. Scientific Reports. 16(1). 1214–1214.
2.
Helbig, Grzegorz, Marta Sobas, Jarosław Piszcz, et al.. (2025). A multi-center study of a machine learning algorithm for identifying undiagnosed patients with myelodysplastic syndrome based on complete blood count data. Blood. 146(Supplement 1). 5629–5629.
3.
Choi, Daniel, Ghaith Abu‐Zeinah, Pouneh Kermani, et al.. (2024). Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 1764–1764. 1 indexed citations
4.
Choi, Daniel, Ghaith Abu‐Zeinah, Pouneh Kermani, et al.. (2024). JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms. Leukemia. 38(11). 2487–2491. 4 indexed citations
5.
Oh, Stephen T., et al.. (2024). MPN-497 Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion. Clinical Lymphoma Myeloma & Leukemia. 24. S436–S436. 1 indexed citations
7.
Sobas, Marta, et al.. (2024). Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms. Annals of Hematology. 103(11). 4545–4556. 3 indexed citations
8.
Bołkuń, Łukasz, Joanna Drozd‐Sokołowska, Ewa Zarzycka, et al.. (2024). A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience. Frontiers in Oncology. 14. 1395992–1395992.
10.
Stuckey, Ruth, Marta Sobas, Alberto Álvarez‐Larrán, et al.. (2024). DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thrombosis and Haemostasis. 124(7). 669–675. 3 indexed citations
11.
Więckowska, Barbara, et al.. (2023). High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis. Journal of Applied Genetics. 64(3). 479–491. 1 indexed citations
12.
Leković, Danijela, Andrija Bogdanović, Marta Sobas, et al.. (2023). Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia. Cancers. 15(16). 4180–4180. 2 indexed citations
13.
Stuckey, Ruth, Jean‐Christophe Ianotto, Marco Santoro, et al.. (2023). Prediction of major bleeding events in 1381 patients with essential thrombocythemia. International Journal of Hematology. 118(5). 589–595. 5 indexed citations
14.
Stuckey, Ruth, Jean‐Christophe Ianotto, Marco Santoro, et al.. (2022). Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study. British Journal of Haematology. 199(1). 86–94. 4 indexed citations
15.
Sobas, Marta, Kamel Laribi, Joanna Drozd‐Sokołowska, et al.. (2021). Primary cutaneous indolent B-cell lymphomas – a retrospective multicenter analysis and a review of literature. Acta Oncologica. 60(10). 1361–1368. 8 indexed citations
16.
Shouval, Roni, Joshua Fein, Ivetta Danylesko, et al.. (2019). Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis. Bone Marrow Transplantation. 55(1). 147–156. 7 indexed citations
17.
Helbig, Grzegorz, Tomasz Sacha, Andrzej Mital, et al.. (2019). Zaawansowana mastocytoza układowa — stanowisko ekspertów dotyczące postępowania diagnostycznego i leczniczego. Jagiellonian University Repository (Jagiellonian University). 10(3). 113–123.
18.
Sobas, Marta, Tomasz Wróbel, Maria Podolak‐Dawidziak, et al.. (2017). Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report. SHILAP Revista de lepidopterología. 2017. 1–4. 5 indexed citations
19.
20.
Sobas, Marta, et al.. (2006). Encefalitis límbica paraneoplásica y carcinoma epidermoide del seno piriforme. Anales de Medicina Interna. 23(7). 331–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026